Comprehensive Research Journal of Biological Science (CRJBS) Vol.1(1) pp. 001 - 005 December, 2013 Available online http://crjournals.org/CRJBS/Index.htm Copyright 2013 Comprehensive Research Journals Review
Hepatotoxicity: mini review Saim Jamil M1, Akram M*2, Halima Nazar1, Khan Usmanghani1, Asif M. H2, Osama Alam1, Tasneem Qureshi1, Mohiuddin E1
1Faculty of Eastern Medicine and Surgery, Hamdard University Karachi, Pakistan
2Department of Eastern Medicine and Surgery, Faculty of Medical and Health Sciences, The University of Poonch,
Rawalakot, Azad Jammu and Kashmir, Pakistan
There are limited data regarding the frequency and proportionality of drug-induced hepatotoxicity. We sought to determine the scope of drug-induced hepatitis as seen in a community-based hepatology referral service. The present work constitutes a review of the drug induced hepatitis in literature. We performed PUBMED, EMBASE, and CENTRAL searches for research papers of drug induced hepatitis. Due to lack of reliable markers it is very difficult to diagnose drug-induced liver injury. Similarly it is very difficult to differentiate between drug-induced hepatotoxicity and any idiosyncratic reaction caused by a toxin. Complexity increases by the simultaneous use of multiple drugs. Liver function returns to normal in most of the cases when the offending drug is stopped. The manuscript plays an important role in the field of hepatotoxicity. This is focused review referring different published article on this topic. Keywords: Hepatitis, drug induced hepatitis, literature review INTRODUCTION Hepatotoxicity implies chemical-driven liver damage.
drug in hepatitis. Modern drugs either lose effects or
The term also applies to radioactive materials and drugs
cause one or another side disease of any pathway.
of synthetic origin which may cause liver damage. The
Drug-induced liver injury is one of the major concerns
most susceptible organ to toxicity from foreign agents is
pertaining to drug design for curative and preventive
liver, due to its major role in transforming and clearing
health care function. Therefore it creates problem in the
chemicals. Certain medicinal agents may injure the liver
liver in its proper function and also poses threat for its
when taken in therapeutic range. A lot of chemicals used
injury leading to the manifestation of drug toxicity.
in laboratories, industries, drugs or even herbal
Objective of this paper is to review the published papers
remedies can induce hepatotoxicity. Thus chemicals or
drugs which have the tendency to induce liver injury are
called Hepatotoxins. Medical world faces with the
serious problem of the development of safe and effective
Pathophysiology
Correspondence Author E-mai: makram_0451@hotmail.com
presented by Jaimer and co-workers where in the age
greater than 35 years was the target factor for the drug-
induced hepatitis in patients who were treated with
cause in many countries. In the developed countries, the
antituberculosis. A study was conducted to determine
incidence of virally induced disease has declined
whether infection with either the hepatitis C virus or
significantly in recent years, with most cases now arising
human immunodeficiency virus was to be treated with
antituberculosis drugs material. The treatment of
paracetamol. However, results have clearly showed that
tuberculosis in patients who were suffering with drug
use of liver transplantation emergency (William, 2003).
induced liver injury as well as suffering from hepatitis C
A study on Ceftriaxone induces toxic hepatitis actively
and HIV. The patients with hepatitis C who were positive
in the liver system. Toxic hepatitis or drug-induced liver
and who developed drug-induced hepatitis on repeated
injury include manifestation of clinical illness which range
reintroducing of the TB drugs were offered a liver biopsy.
from mild to moderate as well as biochemical
If inflammation that cause with hepatitis C, the sample
abnormalities in acute liver failure. There is advantage of
was presented for biopsy, treatment with interferon alpha
a long half life, wide spectrum, high tissue penetration as
started and was the anti TB drugs. During the 18 month
well as a good safety profile of ceftriaxone which is
of the study, 22 patients were found having drug induced
regarded as third generation cephalosporin. The choice
for the treatment of childhood infections which is
The relative risk of hepatitis C or HIV positive was
regarded in previous studies have shown that few cases
determined as fivefold and fourfold, (p <0,05). Partially,
of high aspartate and alanine aminotransferases, with
four patients were treated with alpha-interferon and anti-
three cases of hepatitis have been caused by
TB resurgence therapy was shown having liver injury
ceftriaxone. It has been brought to the notice to cite a
(Koziel and Peters, 2007). Although statins are well
case of drug-induced toxic hepatitis in a patient who was
tolerated medications, recent cases of autoimmune
treated with ceftriaxone for acute tonsillitis (Erdal and
hepatitis (AIH) associated with statins use have been
documented (Nasil, 2004). Satoshi Nakayama studied
the overlap syndrome of autoimmune hepatitis and
hepatotoxicity as of paramount importance. Clinical and
primary billiary cirrhosis induced by Fluvastatin. A 59-
laboratory action of non-steroidal anti-inflammatory
year old man reported with liver damage, which occur 1
drugs are mentioned in great detail in text.
month after initiation of therapy with fluvastatin and
Hepatotoxicity is one of the rare side effects of aspirin,
continued after stopping the drug. Although drug-
indomethacin, naproxen, phenylbutazone, sulindac and
induced liver damage could have a positive antibody test
other drugs. Diclofenac sodium is a potent and widely
used non-steroidal anti-inflammatory and analgesic
antibodies M2 21 price index) point that autoimmune
composite. It ranks among the strongest of this type of
liver disease is generated. Liver biopsy findings were
medications while among the better tolerated diclofenac
consistent with overlapping autoimmune hepatitis and
metabolites excreted in urine and into bile. Experiments
primary biliary cirrhosis. Treatment with prednisone and
displayed that the main route of drug life is different in
ursodeoxycholic acid resulted in a better clinical
different species, urinary excretion is most important to
response. In patient the exhibition of autoimmune
humans. The lack of enterohepatic in human being
hepatitis and primary biliary cirrhosis overlap syndrome
accounts for the reduced gastrointestinal toxicity of this
was triggered by statin one year later as the onset
drug. Side effects of liver function are very rare. Seaman
et al. has reported and these has also been verified in
experimental and are extensively cited in medical
literature. In one study, two patients developed acute
Literature review
hepatotoxicity soon after initiating treatment with
Over the last five years, two drugs have been
withdrawn from the market which can cause severe liver
clavulanate-induced hepatitis has been pinpointed.
damage, potential risks that were not fully recognized
Drug-induced hepatitis immune allergic effects of
during the pre-approval clinical tests. Drug-induced
patients are caused by the drug in clinical settings of
hepatic injury is the most common reason given for
adverse stage of development. This could be due to
withdrawal, representing more than 50 percent of cases
metabolic or immunologic idiosyncrasy. The presence of
of acute liver failure in different countries around the
an immunologic idiosyncrasy may be thought due to
world. The recent endeavor has been directed toward a
HLA associated. An investigation was conducted where
better understanding of these facts in order to improve
in 35 patients with biopsy-documented amoxicillin-
results and contain drug induced liver injury (Dienstag,
2008). Acute liver failure is a rare disorder with high
biochemically monitored. HLA-A and B were typed
mortality and resource cost (William and George, 2010).
using alloantisera along with 300 controls. Amoxicillin-
In the developing countries, viral causes dominated by
clavulanate-induced hepatitis associated with DRB1*
infection with hepatitis C are recognized as a common
1501-DRB5 * 0101-DQB1 * 0602 haplotype yielded
results that temper immune-mediated HLA class II
as an anesthetic was introduced in 1950 and thus
antigens, is found to exert its activity on the
proved its effectiveness in surgery. Two types of
pathogenesis of drug-induced hepatitis immunoallergic
halothane associated hepatotoxicity have been cited:
(Marc, 1996). Minocycline as a cause of drug-induced
type 1, or mild hepatitis, related with elevated
autoimmune hepatitis reported by (Neal and Naseer,
transminase levels and self-limiting symptoms and type
2000) where in clinical and liver biopsy morphological
2 or severe hepatotoxicity connected with acute fatal
liver failure and its fatality in many cases. Hepatotoxicity
minocycline autoimmune hepatitis (group 1). Serum
is most likely found with the immune system, based on
laboratory values were compared with liver biopsy
many elements. The free radicals generated by
findings from group 1 with those from 10 patients with
metabolism of halothane in the liver may alter cellular
sporadic autoimmune hepatitis (group 2). All patients in
proteins and introduce neo-antigens to the immune
group 1 were assessed having positive serum
system. These neo-antigens produce a more severe
antinuclear antibodies, but no one observed having
reaction after multiple exposures. Majority cases of
positive serum anti-smooth muscle antibodies. The
hepatitis type 2 occur after repeated contact. It is
morphological determination of the biopsy group 1 was
interesting to note here that new halogenated
the response with those of autoimmune hepatitis in all 4
anesthetics such as enflouranio, and desflurane are not
patients. However, 1 of these biopsy specimens shown
metabolized in the liver that led to the concern (Pieman
scattered eosinophils, in comparison with autoimmune
and Nastran, 2011). Raquel and co-workers have
hepatitis. The mean histological activity index scores for
worked on the genetic polymorphism of NAT2, CYP2E1
patients in Groups 1 and 2 was respectively, 6.7 and 5.4
and not patient in group 1 mark bridging fibrosis or
antituberculosis drug-induced hepatitis in tuberculosis
cirrhosis, compared with 4 of 10 patients in group 2.
patients. The drug used was isoniazid which is used in
antituberculosis treatment plan is also the drug
hepatitis is alike autoimmune hepatitis. The absence of
implicated in hepatotoxicity. The differences in INH-
eosinophils cannot be predicted as an attribute the
induced toxicity have been attributed to genetic
possibility a minocycline cause. If the drug is unmasking
variability more posts as NAT2, CYP2E1, GSTM1 and
GSTT1, that code for enzymes that metabolize drugs.
differentiation cannot be considered as diagnostic
The polymorphism was studied in these enzymes as
susceptibility factors in anti-TB drug-induced hepatitis
Acute liver failure with concurrent Bupropion and
suffering patients. In a case control having active
Carbimazole treatment plan has been communicated.
tuberculosis participated in this clinical trial. Patients with
Bupropion is an antidepressant and has been in use as
a history of anti-TB drug-induced acute hepatitis (cases
an aid for smoking cessation. It also inhibits dopamine
with up to 3 times the upper limit of normal serum
neurons and norepinephrine and enhances the effect of
transaminases and symptoms of hepatitis) and patients
norepinephrine and dopamine, with no appreciable effect
without evidence of TB effects liver function (controls)
on monoamine oxidase activity. Till date the studies
were genotyped for NAT2, CYP2E1, GSTM1 and
given in the literature reveal that bupropion is found
GSTT1 polymorphism. With slow onset having a higher
connected with hepatotoxicity. However case reports
incidence of hepatitis from intermediate/rapid acetylators
are available where in the patients made a smooth
[22% (18/82) versus 9,8% (6/61), odds ratio (OR),2,86,
recovery during 8 weeks period after the initial
95% confidence interval (CI), 1,06 – 7,68, p= 0,04).
presentation by the patients. The hepatotoxicity of
Logistic regression showed that the slow acetylation
carbimazole has been quite amply proved in which acute
status was the independent risk factor (OR 3.59, 95%
CI, 2,53 4, 64, p=0,02) for the appearance of anti-
carbimazole and bupropion (Khoo and Tham, 2003).
tuberculosis drug-induced hepatitis during treatment for
Horng and Chia, (2011), detailed delineation on the
TB with INH systems containing patients (Raquel and
hepatic insufficiency by using Itraconazole as compared
Renata, 2011). Ashima (2010), have put forward a study
with Corticosteroids treatment. Itraconazole have shown
to deal with autoimmune hepatitis diagnosis and
risk of hepatotoxicity because of its low affinity for
treatment in order to make it easy for the health officials
human P-450 enzyme. Although, hepatic failure caused
to differentiate between autoimmune or drug-induced
by itraconazole is rather rare. The case of a 46-year old
hepatitis. Autoimmune hepatitis is an acute inflammatory
woman was investigated who developed liver failure with
natured position by inflammation around the gate,
itraconazole that was administered for the treatment of
onychomycosis. Treatment with corticosteroids found
response to immunosuppressant. One environmental
effective for itraconazole-induced hepatitis, especially in
factor (tropical) is assumed to cause immune-mediated
those patients not responding to conventional treatment.
attack against liver antigens in genetically predisposed
A study conducted based on Halothane-induced
individuals. A variety of clinical presentations have been
hepatitis in developing countries shows that Halothane
observed ranging from chronic indolent disease to
fulminant hepatic failure, and diagnosis requires the
detoxification of foreign material but also become a
exclusion of other causes of liver disease. Treatment
target for toxicity. More than 1000 drugs are utilized with
with corticosteroids should be executed promptly.
idiosyncratic hepatotoxocoty and drug-induced liver
Treatment decision is usually complicated by the diverse
injury. This has created an awareness as well as point
clinical manifestations and its clinical efficacy plan for
for removing viable drugs from the market. Drug-induced
multitude immunosuppressive agents. Achieving normal
hepatotoxicity involved in half of cases of acute liver
liver test and tissue is the ideal indicator for treatment
failure, with paracetamol as the main factor responsible
point. Compensated patients may benefit from liver
for the violation. The liver damage caused by the drug in
transplantation. Long-term prognosis is excellent, with
2.3% of patients hospitalized for jaundice. However,
early and aggressive initiation of therapy. The research
drugs used in drug-induced toxicity could not be figured
work carried out on autoimmune hepatitis gives detailed
out because of the difficulty in diagnosis and the low
frequency of furnishing the data on pharmacovigilance.
pathogenesis, diagnostic parameter, treatment with in
Therefore drug-induced toxicity represents a clinical
pregnancy, and long term effects on cirrhosis and
challenge due to the large number of reported
hepato-cellular carcinoma in patients (Jou and Muir,
hepatotoxic drugs in use, the wide range of liver damage
because of absence of clinical findings and the diagnosis
hepatitis, drug-induced autoimmunity or classical
on the effect on liver. Therefore the assessment of drug-
autoimmune hepatitis was the subject that was
induced liver injury should be the first priority while
presented by Altintas et al. It was the subject of the
developing dosage form design (Ryder, 2008).
Drug-induced liver injury is a growing problem along
progesterone for women has been utilized in
with complication of drugs prescribed, because the liver
gynecological complaints and disorders. But the
is for the metabolic disposal of drugs and foreign
material. Although drugs are supposed to metabolize
dydrogesterone-induced hemolytic anemia has been
without damage, the liver damage has been constantly
dealt extensively in literature findings. The authors have
observed an adverse event. Drugs produce metabolites
proposed a case of hepatitis and warm antibody
causing liver damage in a single dose fashion. Most drug
hemolytic anemia due to dydrogestrone and given its
material is a toxic byproduct only in rare individuals.
assessment for the possible differentiation in the
Injury to hepatocytes results either directly by the
diagnosis of hepatitis induction and drug induced
disruption of intracellular function or membrane integrity
or indirectly by immune-mediated membrane damage.
Kazuto (2008), have cited a default study and
Genetic alterations in enzymes harmful metabolite
furnished the practical guidelines to combat drug-
competition in drugs, and depletion of substrates
induced liver injury. The range of the drug induced liver
required to detoxify the metabolite in the liver so that it
injury is both diverse and complex in its onset on liver
can be prevented. Drug-induced hepatotoxicity clearly
function. Neil Kaplawitz has given detailed description on
spelled out the withdrawal of many drugs that produced
drug-induced liver injury. The predominant clinical
severe liver damage, a potential risk that was not
picture is acute hepatitis or cholestasis with clinical
recognized in the pre-approval clinical trials. Drug-
pathological parameter of acute or chronic liver disease
induced liver injury is the leading cause for more than 50
percent of cases of acute liver failure. More than 75
pathogenesis of drug-induced liver disease involves the
percent of cases of idiosyncratic drug reactions have
participation of the parent drug or metabolite that either
given way to option for liver transplantation that has lead
directly affects the biochemistry of cells or to elicit an
to death in some cases. In order to improve the drug not
immune response. Each hepatotoxin is associated with a
to resort to drug-induced liver damage the pathogenesis
distinctive signature on the pattern of loss and latency.
of drug-induced liver damage, common adverse drug
Unpredictable, low frequency, reactions occur in the
reactions is to be understood in a better experimental
background by a higher rate of mild asymptomatic liver
and clinical findings and this should be monitored
injury and these are difficult to detect by monitoring
exclusively to check the types of malaise (William,
investigation on development in toxicogenomics and
Mechanism of drug-induced liver injury is the choice of
proteomics could improve the determination of risk
research in many findings and has depicted the
factors and exploration of idiosyncratic hepatotoxicity
idiosyncratic nature and poor prognosis of drug-induced
liver damage exhibit drug reaction and safety and the
The recent view of research undertaken on drug-
cause of withdrawal of drugs. Drug-induced toxicity is
induced liver injury describe that liver metabolizes
generated by direct hepatotoxic effects of a drug or its
foreign substances and also functionally insert between
metabolites. Parenchymal cell damage create the
site of absorption and systemic circulation (Tainin,
activation of innate and / or adaptive immune cells,
2008). These parameters fulfill the liver with the
which combat inflammatory and tissue hepatotoxic
mediators and propel immune responses against drug-
REFERENCES
related antigens. Understanding the molecular and
Altintas E (2004). Drug induced hepatitis, drug-induced autoimmunity
cellular components with different mechanisms can
or classical autoimmune hepatitis. How we can differentiate: Turk. J.
identify risk factors and eventually develop of a working
methodology to predict and prevent drug-induced liver
Ashima M, Aithal G (2011). A review of current diagnosis and
treatment of hepatitis B. Hep. Res. Treat. 3 (90): 916-920.
Dienstag J (2008). Hepatitis B virus infection. N. Eng. J. Med.
Erdal P, Eren C (2009). Ceftriaxome-induced toxic hepatitis. W. J.
Diagnosis
Horng L, Chia F (2011). Hepatic failure related to itraconazole use
successfully treated by corticosteroids. Hep. Month. 11 (10): 5812-
The first step in diagnosis of drug-induced liver injury is a
suspicion based on careful consideration of recent
Jou J, Muir A (2008). In the clinic Hepatitis C. Ann. Internat. Med. 148:
comprehensive reports on the disease. There are some
cases where the suspicion of drug-induced liver injury is
Kazuto T, Yukihiro S (2008). Practical guidelines for diagnosis and
early management of drug-induced liver injury. W. J. Gastroenterol.
particularly strong. Exclusion of other possible causes,
according to the model of the liver injury is necessary for
Khoo A, Tham L (2003). Acute liver failure with concurrent bupropion
and carbimazole therapy. Ann. Pharmacother. 37: 220-230.
Koziel M, Peters M (2007). Viral hepatitis in HIV infection. N. Eng. J.
Marc L (1996). HLA association of amoxicillin clavulanate-induced
Management
hepatitis. Hum. Immunol. 47:160.
Michael P, Cynthia J (2006). Mechanism of drug-induced liver injury. J.
Early management of drug-induced liver injury will mean
Nasil A (2004). Drug-induced autoimmunity or classical autoimmune
immediate removal of the used drug suspected to be
hepatitis. Turk. J. Gastroenterol. 15 (3): 123-125.
responsible, in accordance with serum level of Alanine
Neal S, Naseer B (2000). Minocycline as a cause of drug-induced
aminotransferase, Alkaline phosphates, and total
autoimmune hepatitis. Am. J. Clin Pathol. 1114: 591-598.
Neil K (2011). Drug-induced liver injury. J. Gastroenterol. 38 (2): 8-44. Pieman H, Nastran M (2011). Halothane-induced hepatitis. Hep.
Raquel L, Renata G (2011). Genetic polymorphism of enzymes. Braz.
CONCLUSION
Ryder S (2008). Acute hepatitis. Brit. Med. J. 322 (7279): 151-153. Satoshi N, Naoya M (2011). Overlap syndrome of autoimmune
Fulminant liver failure by drug-induced hepatotoxicity
hepatitis and primary biliary cirrhosis triggered by Flavaststin. Ind. J.
may require liver transplant. Drugs mostly associated
with drug-induced liver injury include paracetamol, non-
Schapira D (1986). Diclofenac-induced hepatotoxicity. P. Grad. Med. J.
Sjogren M, Cheatham J (2010). Hepatitis A. Gastroin. Liv. Dis. 9: 77-
immunosuppressants and psychiatric drugs. Articles
used in this study showed that the major cause of drug-
Tainin C (2008). Drug-induced liver injury. Med. Bull. 13 (3): 142-144.
induced hepatotoxicity was due to paracetamol, drug
William B, George A (2010). Acute liver failure. Lancet. 376: 190-201.
induced toxicity required liver transplants or withdrawal
William M (1995). Drug-induced Hepatotoxicity. N. Eng. J. Med. 333:
from the drug known to have caused the effects.
William M (2003). Drug-Induced hepatotoxicity. N. Eng. J. Med. 349:
Conflict of interest declaration
Nicotine & Tobacco Research Nicotine & Tobacco Research Advance Access published July 9, 2010 Original Investigation The use of snus for quitting smoking compared with medicinal products Karl Erik Lund, Ph.D., 1 Ann McNeill, Ph.D., 2 & Janne Scheffels, Ph.D. 1 1 Norwegian Institute for Alcohol and Drug Research, Oslo, Norway 2 UK Centre for Tobacco Control Studies
55, rue des Bruyères L-1274 Howald Tel: 26 84 64-1 Fax: 26 84 57 61 http://www.cecluxembourg.lu La Lettre des Consommateurs – Der Verbraucherbrief Midi de l’ Europe Une bonne manière de passer l’heure de midi : de 12.30 à 13.30, un sujet d’ actualité est présenté aux nombreux participants. Le 27 octobre 2010, l’ intervenant élucidera la problématique de la libéral